Current Protein Identity:P03950 New Search
Main Difference Dimensions in This Set
Different construct Different mutation/modification Different assembly state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics

Difference tags compare only the current result set; every original PDB and assembly record remains separate.

Related-Structure Differences

Each row represents one biological assembly in one PDB entry; multiple monomers of the same protein are listed separately.

PDB Entry Assembly / Oligomeric State Construct Mutations and Modifications Ligands, Ions and Non-polymers Experimental Method Experimental Conditions Structure Quality
1A4Y RIBONUCLEASE INHIBITOR-ANGIOGENIN COMPLEX Deposited 1998-02-08 Assembly 1 Protein heterocomplex Heteromer;Protein × 4 PDB declaration: tetrameric(4) Consistent with protein count
Chain B 25–147(123 aa)
Chain E 25–147(123 aa)
Not recorded No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions pH 4.2;THE COMPLEX WAS CRYSTALLIZED FROM 10% PEG4000, 20MM SODIUM CITRATE (PH 4.2), 0.1 AMMONIUM SULPHATE AND 25 MM DTT.
Resolution 2.00 Å R-free 0.286
1ANG CRYSTAL STRUCTURE OF HUMAN ANGIOGENIN REVEALS THE STRUCTURAL BASIS FOR ITS FUNCTIONAL DIVERGENCE FROM RIBONUCLEASE Deposited 1994-01-18 Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 25–147(123 aa)
Not recorded No recorded non-water small molecule X-RAY DIFFRACTION mmCIF provides none of the parsed conditions Resolution 2.40 Å
1AWZ 3D SOLUTION STRUCTURE OF HUMAN ANGIOGENIN DETERMINED BY 1H, 15N NMR SPECTROSCOPY, 30 STRUCTURES Deposited 1997-10-07 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 25–147(123 aa)
Not recorded No recorded non-water small molecule SOLUTION NMR
NMR measurement conditions pH 5;313 K;Ionic strength (raw mmCIF value) 150 mM;Pressure 1
Resolution not provided
1B1E CRYSTAL STRUCTURE OF HUMAN ANGIOGENIN VARIANT K40Q Deposited 1998-11-20 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 1–123(123 aa)
Mutation:K40Q CIT CITRIC ACID × 1 X-RAY DIFFRACTION
X-ray crystallization conditions pH 5.2;289 K;pH 5.2, temperature 289K
Resolution 2.00 Å R-free 0.287
1B1I CRYSTAL STRUCTURE OF HUMAN ANGIOGENIN Deposited 1998-11-20 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 1–123(123 aa)
Non-standard monomer:Yes (specific site not provided by mmCIF) CIT CITRIC ACID × 1 X-RAY DIFFRACTION
X-ray crystallization conditions pH 5.6;pH 5.6
Resolution 1.80 Å R-free 0.273
1B1J CRYSTAL STRUCTURE OF HUMAN ANGIOGENIN VARIANT H13A. Deposited 1998-11-20 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 1–123(123 aa)
Mutation:H13A No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions pH 7.5;pH 7.5
Resolution 2.00 Å R-free 0.319
1GV7 ARH-I, an angiogenin/RNase A chimera Deposited 2002-02-06 Assembly 1 Insufficient information Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 25–81(57 aa)
Chain A 95–147(53 aa)
Mutation:YES Non-standard monomer:Yes (specific site not provided by mmCIF) Mutation:YES Non-standard monomer:Yes (specific site not provided by mmCIF) CIT CITRIC ACID × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION;pH 5.8;289 K;VAPOUR DIFFUSION, 16 C 10 MG/ML PROTEIN, 15 % PEG 4000, 8 % TERT-BUTANOL, 0.3 M AMMONIUM ACETATE, 0.1 M SODIUM CITRATE BUFFER, PH 5.8
Resolution 2.10 Å R-free 0.274
1H0D Crystal structure of Human Angiogenin in complex with Fab fragment of its monoclonal antibody mAb 26-2F Deposited 2002-06-19 Assembly 1 Protein heterocomplex Heteromer;Protein × 3 PDB declaration: trimeric(3) Consistent with protein count
Chain C 25–147(123 aa)
Non-standard monomer:Yes (specific site not provided by mmCIF) SO4 SULFATE ION × 8 GOL GLYCEROL × 6 X-RAY DIFFRACTION
X-ray crystallization conditions pH 6;30% PEG 3350 AND 0.2M LITHIUM SULPHATE PH 6.0-7.5
Resolution 2.00 Å R-free 0.272
1H52 Binding of Phosphate and Pyrophosphate ions at the active site of human Angiogenin as revealed by X-ray Crystallography Deposited 2001-05-18 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 25–147(123 aa)
Non-standard monomer:Yes (specific site not provided by mmCIF) POP PYROPHOSPHATE 2- × 1 X-RAY DIFFRACTION
X-ray crystallization conditions pH 5.2;20MM SODIUM CITRATE, 0.2M SODIUM POTASSIUM TARTARATE, 10% PEG 6000 PH 5.2
Resolution 2.00 Å R-free 0.287
1H53 Binding of Phosphate and Pyrophosphate ions at the active site of human Angiogenin as revealed by X-ray Crystallography Deposited 2001-05-18 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 26–147(122 aa)
Mutation:YES Non-standard monomer:Yes (specific site not provided by mmCIF) CIT CITRIC ACID × 1 PO4 PHOSPHATE ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions pH 5.2;20MM SODIUM CITRATE, 0.2M SODIUM POTASSIUM TARTARATE, 10% PEG 6000 PH 5.2
Resolution 2.00 Å R-free 0.260
1HBY Binding of Phosphate and Pyrophosphate ions at the active site of human angiogenin as revealed by X-ray Crystallography Deposited 2001-04-21 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 25–147(123 aa)
Non-standard monomer:Yes (specific site not provided by mmCIF) PO4 PHOSPHATE ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions pH 6;25% PEG 6000, 0.1M MES, PH 6.0, 0.1M NACL
Resolution 2.00 Å R-free 0.230
1K58 Crystal Structure of Human Angiogenin Variant D116H Deposited 2001-10-10 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 25–147(123 aa)
Mutation:D116H Non-standard monomer:Yes (specific site not provided by mmCIF) No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 5.6;289 K;sodium citrate, 2-propanol, PEG 4000, pH 5.6, VAPOR DIFFUSION, HANGING DROP, temperature 289K
Resolution 2.70 Å R-free 0.360
1K59 Crystal Structure of Human Angiogenin Variant Q117G Deposited 2001-10-10 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 25–147(123 aa)
Mutation:Q117G Non-standard monomer:Yes (specific site not provided by mmCIF) CIT CITRIC ACID × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 5.2;289 K;sodium citrate, PEG 6000, pH 5.2, VAPOR DIFFUSION, HANGING DROP, temperature 289K
Resolution 1.80 Å R-free 0.241
1K5A Crystal structure of human angiogenin double variant I119A/F120A Deposited 2001-10-10 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 25–147(123 aa)
Mutation:I119A,F120A No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 5.6;289 K;ammonium actate, sodium citrate, PEG 4000, pH 5.6, VAPOR DIFFUSION, HANGING DROP, temperature 289K
Resolution 2.33 Å R-free 0.281
1K5B Crystal Structure of Human Angiogenin Variant des(121-123) Deposited 2001-10-10 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 25–147(123 aa)
Mutation:DEL(121-123) Non-standard monomer:Yes (specific site not provided by mmCIF) CIT CITRIC ACID × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 5.2;289 K;sodium citrate, sodium potassium tartrate, PEG 6000, pH 5.2, VAPOR DIFFUSION, HANGING DROP, temperature 289K
Resolution 1.80 Å R-free 0.275
1UN3 CRYSTAL STRUCTURE OF HUMAN ANGIOGENIN VARIANT T44D Deposited 2003-09-04 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 25–147(123 aa)
Mutation:YES Non-standard monomer:Yes (specific site not provided by mmCIF) No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions pH 5.2;15% PEG 4000, 0.02% DIOXANE, 0.2M SODIUM POTASSIUM TARTRATE, 0.02M SODIUM CITRATE BUFFER, PH 5.2
Resolution 1.70 Å R-free 0.223
1UN4 CRYSTAL STRUCTURE OF HUMAN ANGIOGENIN VARIANT T80A Deposited 2003-09-04 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 25–147(123 aa)
Mutation:YES Non-standard monomer:Yes (specific site not provided by mmCIF) CIT CITRIC ACID × 1 X-RAY DIFFRACTION
X-ray crystallization conditions pH 5.2;15% PEG 4000, 0.02% DIOXANE, 0.2M SODIUM POTASSIUM TARTRATE, 0.02M SODIUM CITRATE BUFFER, PH 5.2
Resolution 2.10 Å R-free 0.232
1UN5 ARH-II, AN ANGIOGENIN/RNASE A CHIMERA Deposited 2003-09-04 Assembly 1 Insufficient information Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 25–61(37 aa)
Chain A 66–147(82 aa)
Mutation:YES Mutation:YES CIT CITRIC ACID × 1 X-RAY DIFFRACTION
X-ray crystallization conditions pH 5.4;10% PEG 6000, PH 5.4 0.2M SODIUM POTASSIUM TARTRATE, 0.02M SODIUM CITRATE BUFFER
Resolution 2.60 Å R-free 0.237
2ANG CRYSTAL STRUCTURE OF HUMAN ANGIOGENIN OF THE MET(-1) FORM Deposited 1998-11-12 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 25–147(123 aa)
Not recorded CIT CITRIC ACID × 1 X-RAY DIFFRACTION
X-ray crystallization conditions pH 5.2;pH 5.2
Resolution 2.00 Å R-free 0.286
4AHD Q12L - Angiogenin mutants and amyotrophic lateral sclerosis - a biochemical and biological analysis Deposited 2012-02-06 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 25–147(123 aa)
Mutation:YES No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions 20 % PEG 4K, 0.05 M NA/K TARTRATE, 0.1 M NACL, 0.1 M HEPES PH 7.0
Resolution 2.47 Å R-free 0.249
4AHD Q12L - Angiogenin mutants and amyotrophic lateral sclerosis - a biochemical and biological analysis Deposited 2012-02-06 Assembly 2 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain B 25–147(123 aa)
Mutation:YES No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions 20 % PEG 4K, 0.05 M NA/K TARTRATE, 0.1 M NACL, 0.1 M HEPES PH 7.0
Resolution 2.47 Å R-free 0.249
4AHE K17I - Angiogenin mutants and amyotrophic lateral sclerosis - a biochemical and biological analysis Deposited 2012-02-06 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 25–147(123 aa)
Mutation:YES TLA L(+)-TARTARIC ACID × 1 X-RAY DIFFRACTION
X-ray crystallization conditions 20 % PEG 4K, 0.4 M NA/K TARTRATE, 0.1 M NA CITRATE PH 5.5
Resolution 2.08 Å R-free 0.300
4AHF K17E - Angiogenin mutants and amyotrophic lateral sclerosis - a biochemical and biological analysis Deposited 2012-02-06 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 25–147(123 aa)
Mutation:YES SO4 SULFATE ION × 3 EDO 1,2-ETHANEDIOL × 1 X-RAY DIFFRACTION
X-ray crystallization conditions 20 % PEG 4K, 0.05 M NA/K TARTRATE, 0.1 M NACL, 0.1 M HEPES PH 7.0
Resolution 2.12 Å R-free 0.285
4AHG S28N - Angiogenin mutants and amyotrophic lateral sclerosis - a biochemical and biological analysis Deposited 2012-02-06 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 25–147(123 aa)
Mutation:YES TAR D(-)-TARTARIC ACID × 1 X-RAY DIFFRACTION
X-ray crystallization conditions 20 % PEG 4K, 0.4 M NA/K TARTRATE, 0.1 M NA CITRATE PH 5.5
Resolution 2.45 Å R-free 0.275
4AHH R31K - Angiogenin mutants and amyotrophic lateral sclerosis - a biochemical and biological analysis Deposited 2012-02-06 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 25–147(123 aa)
Mutation:YES TLA L(+)-TARTARIC ACID × 1 X-RAY DIFFRACTION
X-ray crystallization conditions 20 % PEG 4K, 0.05 M NA/K TARTRATE, 0.1 M NACL, 0.1 M HEPES PH 7.0
Resolution 2.50 Å R-free 0.242
4AHI K40I - Angiogenin mutants and amyotrophic lateral sclerosis - a biochemical and biological analysis Deposited 2012-02-06 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 25–147(123 aa)
Mutation:YES No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions 20 % PEG 4K, 0.05 M NA/K TARTRATE, 0.1 M NACL, 0.1 M HEPES PH 7.0
Resolution 2.80 Å R-free 0.278
4AHJ I46V - Angiogenin mutants and amyotrophic lateral sclerosis - a biochemical and biological analysis Deposited 2012-02-06 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 25–147(123 aa)
Mutation:YES TAR D(-)-TARTARIC ACID × 1 X-RAY DIFFRACTION
X-ray crystallization conditions 20 % PEG 4K, 0.05 M NA/K TARTRATE, 0.1 M NACL, 0.1 M HEPES PH 7.0
Resolution 2.03 Å R-free 0.280
4AHK K54E - Angiogenin mutants and amyotrophic lateral sclerosis - a biochemical and biological analysis Deposited 2012-02-06 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 25–147(123 aa)
Mutation:YES No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions 20 % PEG 4K, 0.4 M NA/K TARTRATE, 0.1 M NA CITRATE PH 5.5
Resolution 1.97 Å R-free 0.279
4AHK K54E - Angiogenin mutants and amyotrophic lateral sclerosis - a biochemical and biological analysis Deposited 2012-02-06 Assembly 2 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain B 25–147(123 aa)
Mutation:YES TAR D(-)-TARTARIC ACID × 2 X-RAY DIFFRACTION
X-ray crystallization conditions 20 % PEG 4K, 0.4 M NA/K TARTRATE, 0.1 M NA CITRATE PH 5.5
Resolution 1.97 Å R-free 0.279
4AHL P112L - Angiogenin mutants and amyotrophic lateral sclerosis - a biochemical and biological analysis Deposited 2012-02-06 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 25–147(123 aa)
Mutation:YES TLA L(+)-TARTARIC ACID × 1 X-RAY DIFFRACTION
X-ray crystallization conditions 20 % PEG 4K, 0.4 M NA/K TARTRATE, 0.1 M NA CITRATE PH 5.5
Resolution 2.05 Å R-free 0.303
4AHM V113I - Angiogenin mutants and amyotrophic lateral sclerosis - a biochemical and biological analysis Deposited 2012-02-06 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 25–147(123 aa)
Mutation:YES TLA L(+)-TARTARIC ACID × 1 X-RAY DIFFRACTION
X-ray crystallization conditions 20 % PEG 4K, 0.4 M NA/K TARTRATE, 0.1 M NA CITRATE PH 5.5
Resolution 1.96 Å R-free 0.221
4AHN R121H - Angiogenin mutants and amyotrophic lateral sclerosis - a biochemical and biological analysis Deposited 2012-02-06 Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 25–147(123 aa)
Mutation:YES CL CHLORIDE ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions 20 % PEG 4K, 0.05 M NA/K TARTRATE, 0.1 M NACL, 0.1 M HEPES PH 7.0
Resolution 2.98 Å R-free 0.283
4AOH Structural snapshots and functional analysis of human angiogenin variants associated with Amyotrophic Lateral Sclerosis (ALS) Deposited 2012-03-27 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 24–147(124 aa) Fragment:RESIDUES 24-147
Not recorded TAR D(-)-TARTARIC ACID × 1 TLA L(+)-TARTARIC ACID × 1 X-RAY DIFFRACTION
X-ray crystallization conditions pH 7;20 % PEG 4K, 0.05 M NA/K TARTRATE, 0.1 M NACL, 0.1 M HEPES PH 7.0
Resolution 1.04 Å R-free 0.188
4B36 Crystal Structure of Human Angiogenin with an Engineered Loop Exhibits Conformational Flexibility at the Functional Regions of the Molecule Deposited 2012-07-20 Assembly 1 Insufficient information Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 25–107(83 aa) Fragment:RESIDUES 25-107,111-120,116-147
Chain A 116–147(32 aa) Fragment:RESIDUES 25-107,111-120,116-147
Not recorded No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions 1.75-2.5 M NACL
Resolution 1.76 Å R-free 0.285
4B36 Crystal Structure of Human Angiogenin with an Engineered Loop Exhibits Conformational Flexibility at the Functional Regions of the Molecule Deposited 2012-07-20 Assembly 2 Insufficient information Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain B 25–107(83 aa) Fragment:RESIDUES 25-107,111-120,116-147
Chain B 116–147(32 aa) Fragment:RESIDUES 25-107,111-120,116-147
Not recorded CL CHLORIDE ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions 1.75-2.5 M NACL
Resolution 1.76 Å R-free 0.285
5EOP Crystal structure of human Angiogenin at 1.35 Angstroms resolution Deposited 2015-11-10 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 26–146(121 aa) Fragment:UNP residues 26-166
Not recorded No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION;pH 7;289 K;Malic acid/NaOH pH 7.0 PEG 3350
Resolution 1.35 Å R-free 0.192
5EPZ Human Angiogenin in complex with sulphate anions at a basic solution Deposited 2015-11-12 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 26–145(120 aa) Fragment:UNP residues 26-145
Not recorded SO4 SULFATE ION × 4 GOL GLYCEROL × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION;pH 8;289 K;0.1 M Tris/HCl buffer pH 8.0, 2.4 M ammonium sulphate
Resolution 1.85 Å R-free 0.217
5EQO Human Angiogenin in complex with sulphate anions at an acidic solution Deposited 2015-11-13 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 25–145(121 aa)
Not recorded SO4 SULFATE ION × 6 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION;pH 6;289 K;0.1 M sodium cacodylate pH 6.0 2.0 M ammonium sulphate
Resolution 2.40 Å R-free 0.250
5M9A Human angiogenin PD variant H13R Deposited 2016-11-01 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 25–147(123 aa)
Mutation:H13R TAR D(-)-TARTARIC ACID × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;289 K;0.2 M Na/K tartrate 20% PEG 3350
Resolution 1.95 Å R-free 0.297
5M9C Human angiogenin ALS variant K40R Deposited 2016-11-01 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 25–147(123 aa)
Mutation:K40R TAR D(-)-TARTARIC ACID × 1 PEG DI(HYDROXYETHYL)ETHER × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 5.5;289 K;0.4 M Na/K tartrate 0.1 M Na citrate 20 % PEG 4000
Resolution 2.05 Å R-free 0.231
5M9G Human angiogenin PD variant K54R Deposited 2016-11-01 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 25–147(123 aa)
Mutation:K54R TAR D(-)-TARTARIC ACID × 1 PEG DI(HYDROXYETHYL)ETHER × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 7;289 K;0.2 M Na/K tartrate 0.1 M HEPES 3% propanol 20% PEG 8000
Resolution 2.28 Å R-free 0.271
5M9J Human angiogenin PD variant K60E Deposited 2016-11-01 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 25–147(123 aa)
Not recorded TLA L(+)-TARTARIC ACID × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 6.5;289 K;0.2 M Na/K tartrate 0.1 M Na cacodylate 25% PEG 4000
Resolution 1.90 Å R-free 0.216
5M9M Human angiogenin PD variant Q77P Deposited 2016-11-01 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 25–147(123 aa)
Not recorded SO4 SULFATE ION × 2 PGE TRIETHYLENE GLYCOL × 1 EDO 1,2-ETHANEDIOL × 2 BTB 2-[BIS-(2-HYDROXY-ETHYL)-AMINO]-2-HYDROXYMETHYL-PROPANE-1,3-DIOL × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;pH 5.5;289 K;0.2 M ammonium sulphate 0.1 M bis-tris methane 25% PEG 3350
Resolution 1.65 Å R-free 0.270
5M9M Human angiogenin PD variant Q77P Deposited 2016-11-01 Assembly 2 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain B 25–147(123 aa)
Not recorded SO4 SULFATE ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;pH 5.5;289 K;0.2 M ammonium sulphate 0.1 M bis-tris methane 25% PEG 3350
Resolution 1.65 Å R-free 0.270
5M9M Human angiogenin PD variant Q77P Deposited 2016-11-01 Assembly 3 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain C 25–147(123 aa)
Not recorded SO4 SULFATE ION × 4 EDO 1,2-ETHANEDIOL × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;pH 5.5;289 K;0.2 M ammonium sulphate 0.1 M bis-tris methane 25% PEG 3350
Resolution 1.65 Å R-free 0.270
5M9M Human angiogenin PD variant Q77P Deposited 2016-11-01 Assembly 4 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain D 25–147(123 aa)
Not recorded SO4 SULFATE ION × 4 PGE TRIETHYLENE GLYCOL × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;pH 5.5;289 K;0.2 M ammonium sulphate 0.1 M bis-tris methane 25% PEG 3350
Resolution 1.65 Å R-free 0.270
5M9P Human angiogenin ALS variant T80S Deposited 2016-11-02 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 25–147(123 aa)
Not recorded SO4 SULFATE ION × 4 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 5.5;289 K;0.2 M ammonium sulphate 0.1 M bis-tris propane 25% PEG 3350
Resolution 1.80 Å R-free 0.285
5M9Q Human angiogenin PD variant R95Q Deposited 2016-11-02 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 25–147(123 aa)
Not recorded SO4 SULFATE ION × 4 PEG DI(HYDROXYETHYL)ETHER × 3 PGE TRIETHYLENE GLYCOL × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;pH 6.5;289 K;0.2 M ammonium sulphate 0.1 M Na cacodylate 30% PEG 8000
Resolution 1.35 Å R-free 0.179
5M9R Human angiogenin ALS variant F100I Deposited 2016-11-02 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 25–147(123 aa)
Not recorded TAR D(-)-TARTARIC ACID × 1 TLA L(+)-TARTARIC ACID × 1 PEG DI(HYDROXYETHYL)ETHER × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 6.5;289 K;0.2 M Na/K tartrate 0.1 M Na cacodylate 20% PEG 4000
Resolution 1.44 Å R-free 0.195
5M9R Human angiogenin ALS variant F100I Deposited 2016-11-02 Assembly 2 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain B 25–147(123 aa)
Not recorded TAR D(-)-TARTARIC ACID × 1 TLA L(+)-TARTARIC ACID × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 6.5;289 K;0.2 M Na/K tartrate 0.1 M Na cacodylate 20% PEG 4000
Resolution 1.44 Å R-free 0.195
5M9S Human angiogenin ALS variant V103I Deposited 2016-11-02 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 25–147(123 aa)
Not recorded TAR D(-)-TARTARIC ACID × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 6.5;289 K;0.2 M Na/K tartrate 0.1 M MES 20% PEG 4000
Resolution 1.85 Å R-free 0.264
5M9T Human angiogenin ALS variant H114R Deposited 2016-11-02 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 25–147(123 aa)
Not recorded GOL GLYCEROL × 1 BO4 BORATE ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 8.5;289 K;0.01 M Na borate 1.1 M Na citrate
Resolution 2.20 Å R-free 0.236
5M9T Human angiogenin ALS variant H114R Deposited 2016-11-02 Assembly 2 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain B 25–147(123 aa)
Not recorded No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 8.5;289 K;0.01 M Na borate 1.1 M Na citrate
Resolution 2.20 Å R-free 0.236
5M9V Human angiogenin PD/ALS variant R121C Deposited 2016-11-02 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 25–147(123 aa)
Not recorded TLA L(+)-TARTARIC ACID × 1 GSH Glutathione × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 6.5;289 K;0.2 M Na/K tartrate 0.1 M bis-tris propane 16% PEG 4000
Resolution 1.70 Å R-free 0.239
7NPM X-ray structure of the adduct formed upon reaction of oxaliplatin with human angiogenin Deposited 2021-02-27 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain AAA 26–146(121 aa) Fragment:UNP residues 26-166
Not recorded PT PLATINUM (II) ION × 3 TAR D(-)-TARTARIC ACID × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 5.1;298 K;10 % PEG6K, 20 mM sodium citrate pH 5.1, 0.2 M sodium/potassium tartrate
Resolution 1.86 Å R-free 0.254
7PNJ Human Angiogenin quardruple mutant-S28AT36AS37AS87A Deposited 2021-09-07 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 25–145(121 aa)
Not recorded CIT CITRIC ACID × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;289 K;100 mM SODIUM CITRATE PH 5.6, 25% (w/v) PEG 4000
Resolution 3.10 Å R-free 0.276
7PNP Human Angiogenin mutant-S28A Deposited 2021-09-07 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 25–147(123 aa)
Not recorded No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;289 K;Malic acid/NaOH pH 7.0, PEG 3350
Resolution 1.80 Å R-free 0.254
7PNR Human Angiogenin mutant-S28AT36AS37A Deposited 2021-09-07 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 25–145(121 aa)
Not recorded No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;289 K;Malic acid/NaOH pH 7.0, PEG 3350
Resolution 1.60 Å R-free 0.201
8AF0 Crystal structure of human angiogenin and RNA duplex Deposited 2022-07-15 Assembly 1 Protein–RNA Homooligomer;Protein × 2 PDB declaration: tetrameric(4) Consistent with all polymers
Chain A 25–147(123 aa)
Chain B 25–147(123 aa)
Mutation:H114A Mutation:H114A GOL GLYCEROL × 4 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;277.15 K;200 mM NaCl, 20 % (w/v) PEG6000, 100 mM Hepes pH 7.0
Resolution 2.43 Å R-free 0.268
9BDL 80S ribosome with angiogenin Deposited 2024-04-12 Assembly 1 Protein–RNA Heteromer;Protein × 75 PDB declaration: 82-meric(82) Consistent with all polymers
Chain ANG 1–147(147 aa)
Not recorded No recorded non-water small molecule ELECTRON MICROSCOPY
cryo-EM buffer pH 7
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 2.80 Å
9BDN 80S ribosome with angiogenin and tRNAAla Deposited 2024-04-12 Assembly 1 Protein–RNA Heteromer;Protein × 77 PDB declaration: 85-meric(85) Consistent with all polymers
Chain ANG 1–147(147 aa)
Not recorded No recorded non-water small molecule ELECTRON MICROSCOPY
cryo-EM buffer pH 7
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 3.10 Å
9BDP 80S ribosome bound with angiogenin and complex of eEF1A and Ala-tRNAAla Deposited 2024-04-12 Assembly 1 Protein–RNA Heteromer;Protein × 78 PDB declaration: 86-meric(86) Consistent with all polymers
Chain ANG 1–147(147 aa)
Not recorded No recorded non-water small molecule ELECTRON MICROSCOPY
cryo-EM buffer pH 7
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 3.70 Å